Company Analysis 4DMedical Limited
1. Summary
Advantages
- Price (0.2279 $) is less than fair price (0.2979 $)
- Current debt level 4.22% is below 100% and has decreased over 5 years from 33.33%.
Disadvantages
- Dividends (0%) are below the sector average (2.28%).
- The stock's return over the last year (-28.87%) is lower than the sector average (5.15%).
- The company's current efficiency (ROE=-40.4%) is lower than the sector average (ROE=12.46%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| 4DMedical Limited | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0% | 0.6% | -0.6% |
| 90 days | -33% | -1.2% | 5.7% |
| 1 year | -28.9% | 5.2% | 9% |
FDMDF vs Sector: 4DMedical Limited has significantly underperformed the "Healthcare" sector by -34.02% over the past year.
FDMDF vs Market: 4DMedical Limited has significantly underperformed the market by -37.84% over the past year.
Stable price: FDMDF is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: FDMDF with weekly volatility of -0.5552% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (0.2279 $) is lower than the fair price (0.2979 $).
Price significantly below the fair price: The current price (0.2279 $) is 30.7% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (54.24).
P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (59.87).
4.3. P/BV
P/BV vs Sector: The company's P/BV (3.22) is lower than that of the sector as a whole (4.2).
P/BV vs Market: The company's P/BV (3.22) is higher than that of the market as a whole (3.17).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (74.94) is higher than that of the sector as a whole (4.62).
P/S vs Market: The company's P/S indicator (74.94) is higher than that of the market as a whole (3.43).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-6.37) is lower than that of the sector as a whole (14.71).
EV/Ebitda vs Market: The company's EV/Ebitda (-6.37) is lower than that of the market as a whole (40.12).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 1.27% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (1.27%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (0.5351%).
5.4. ROE
ROE vs Sector: The company's ROE (-40.4%) is lower than that of the sector as a whole (12.46%).
ROE vs Market: The company's ROE (-40.4%) is lower than that of the market as a whole (41.73%).
5.5. ROA
ROA vs Sector: The company's ROA (-27.74%) is lower than that of the sector as a whole (6.23%).
ROA vs Market: The company's ROA (-27.74%) is lower than that of the market as a whole (29.55%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (15.34%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (10.99%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '2.28%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
